Markets:

Overview

News

Currencies

International

Treasuries

scPharmaceuticals Inc. - Common Stock (NQ:SCPH)

5.670 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 6, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about scPharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 Next >

Expert Ratings for scPharmaceuticals ↗

November 10, 2022

Analysts have provided the following ratings for scPharmaceuticals (NASDAQ:SCPH) within the last quarter:

Via Benzinga

Short Volatility Alert: AscPharmaceuticals Inc. ↗

October 13, 2022

On Wednesday, shares of scPharmaceuticals Inc. (NASDAQ: SCPH) experienced volatile short activity. After the activity, the stock price went up +1.75% to $5.70. The overall sentiment for SCPH has been...

Via Benzinga

Why Laser Photonics Shares Jumped By Around 44%; Here Are 72 Biggest Movers From Yesterday ↗

October 12, 2022

Gainers FedNat Holding Company (NASDAQ: FNHC) shares climbed 107.7% to close at $0.3395 on Tuesday.

Via Benzinga

FDA Approves scPharmaceuticals' Self-Administered Med For Congestion in Chronic Heart Failure ↗

October 10, 2022

Via Benzinga

Recap: scPharmaceuticals Q1 Earnings ↗

May 16, 2022

scPharmaceuticals (NASDAQ:SCPH) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

US Stocks Open Lower, Dow Falls 100 Points ↗

October 11, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping around 100 points on Tuesday.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2022 ↗

October 11, 2022

Upgrades

Via Benzinga

The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline ↗

August 18, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

Alphabet To $134? Plus This Analyst Slashes Price Target On McDonald's ↗

October 11, 2022

Credit Suisse cut the price target on Alphabet Inc. (NASDAQ: GOOGL) from $140 to $134. Credit Suisse analyst Stephen Ju maintained an Outperform rating on the stock. Alphabet shares fell 1.2% to $96.69...

Via Benzinga

Bilibili, H World Group And Other Big Losers From Monday ↗

October 11, 2022

U.S. stocks closed lower with the Nasdaq Composite dropping more than 100 points on Monday. Here is the list of some big stocks recording losses in the previous session.

Via Benzinga

Dow Rises 30 Points; Crude Oil Down 2% ↗

October 10, 2022

U.S. stocks traded mixed toward the end of trading, with the Dow Jones gaining around 30 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

October 10, 2022

Gainers

Via Benzinga

Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday ↗

October 11, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...

Via Benzinga

Wall Street Pulls Back As Chip Stocks Dent Nasdaq ↗

October 10, 2022

Falling semiconductor stocks are weighing on the Nasdaq Composite (IXIC) this afternoon, with the tech-laden benchmark hitting its lowest level since September 2020.

Via Talk Markets

Why Is ACM Research (ACMR) Stock Down 26% Today? ↗

October 10, 2022

ACM Research (ACMR) stock is taking a beating on Monday after the U.S. placed restrictions on exports of certain chip technology.

Via InvestorPlace

Why Is Applied DNA (APDN) Stock Up 70% Today? ↗

October 10, 2022

Applied DNA (APDN) stock is rocketing higher on Monday after the company announced a massive order for its LinearDNA product.

Via InvestorPlace

Nasdaq Dips 150 Points; Gold Down 2% ↗

October 10, 2022

U.S. stocks pared gains midway through trading, with the Dow Jones dropping more than 100 points on Monday.

Via Benzinga

Why Is scPharmaceuticals (SCPH) Stock in the Spotlight Today? ↗

October 10, 2022

It's a good-news, bad-news situation for SCPH stock today, but mostly bad news as scPharmaceuticals agrees to take on high-interest debt.

Via InvestorPlace

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

October 10, 2022

Gainers NeuroMetrix (NASDAQ:NURO) shares increased by 23.0% to $3.48 during Monday's pre-market session. The company's market cap stands at $24.8 million.

Via Benzinga

Why Applied DNA Sciences Shares Are Trading Higher By Around 65%, Here Are 54 Stocks Moving In Monday's Mid-Day Session ↗

October 10, 2022

Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares jumped 64.5% to $2.03 after the company announced it has received its largest single purchase order for LinearDNA™ valued above the...

Via Benzinga

Why Myovant Sciences Is Trading Higher By Over 26%; Here Are 31 Stocks Moving Premarket ↗

October 03, 2022

Gainers Wearable Devices Ltd. (NASDAQ: WLDS) rose 58% to $1.39 in pre-market trading after declining around 8% on Friday. Wearable Devices, last week, posted a 1H loss of $0.18 per share.

Via Benzinga

AstraZeneca-Merck's Prostate Cancer Combo Drug, 3rd Try For scPharma, 3 FDA Panel Decisions And More: October's Key PDUFA Catalysts Biotech Investors Must Know ↗

October 02, 2022

Most FDA decisions scheduled for September yielded positive results, but there were stray disappointments as well. Seven new molecular entities, or NMEs, were approved during the month, taking the...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 2, 2022 ↗

August 02, 2022

Upgrades

Via Benzinga

scPharmaceuticals Shares Are Trading High Following FDA's Acceptance of NDA for FUROSCIX ↗

May 16, 2022

scPharmaceuticals Inc. (NASDAQ: SCPH) announced that the U.S. Food and Drug Administration (FDA) has accepted its New Drug Application (NDA) of the drug candidate FUROSCIX, for the treatment of...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For September 9, 2021 ↗

September 09, 2021

Upgrades According to Benchmark, the prior rating for TopBuild Corp (NYSE:

Via Benzinga

The Daily Biotech Pulse: Coherus Soars On Lung Cancer Data, Illumina Closes On Grail Buy Without Regulatory Clearance, Adagene Strikes Collaboration With Merck ↗

August 19, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 18) AbbVie Inc. (NYSE: ABBV)...

Via Benzinga

The Daily Biotech Pulse: ScPharma's Positive Data, Lilly Goes Shopping, LeMaitre Pre-Announces Q2 Revenues ↗

July 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 13) Biohaven Pharmaceutical...

Via Benzinga

26 Stocks Moving in Wednesday's Pre-Market Session ↗

July 14, 2021

Gainers Yunhong CTI Ltd. (NASDAQ: CTIB) shares rose 35.6% to $3.54 in pre-market trading after jumping around 12% on Tuesday. Oxbridge Re Holdings Limited (NASDAQ: OXBR) shares...

Via Benzinga

scPharma's Furoscix Can Potentially Cut Hospital Admission/Readmission Costs For Heart Failure Patients ↗

July 14, 2021

scPharmaceuticals Inc (NASDAQ: SCPH) announced top-line results from its FREEDOM-HF study evaluating overall and heart failure-related costs of treating congestion...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

July 13, 2021

Gainers scPharmaceuticals (NASDAQ:SCPH) ...

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.